Autolus Therapeutics Plc (AUTL)
1.70
+0.05
(+3.03%)
USD |
NASDAQ |
May 22, 16:00
1.71
+0.01
(+0.59%)
Pre-Market: 20:00
Autolus Therapeutics Free Cash Flow : -295.51M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Biodexa Pharmaceuticals Plc | -8.310M |
| NuCana Plc | -9.929M |
| Mereo BioPharma Group Plc | -27.29M |
| Bicycle Therapeutics Plc | -231.83M |
| DBV Technologies SA | -152.10M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -65.21M |
| Cash from Investing (Quarterly) | 95.99M |
| Cash from Financing (Quarterly) | -2.058M |
| Free Cash Flow Per Share (Quarterly) | -0.2551 |
| Free Cash Flow to Equity (Quarterly) | -85.43M |
| Free Cash Flow to Firm (Quarterly) | -56.65M |
| Free Cash Flow Yield | -65.31% |